Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CARA |
---|---|---|
09:32 ET | 3232 | 0.8025 |
09:34 ET | 18166 | 0.7905 |
09:38 ET | 700 | 0.7885 |
09:41 ET | 300 | 0.78 |
09:43 ET | 2864 | 0.7799 |
09:50 ET | 300 | 0.7689 |
09:52 ET | 1155 | 0.7605 |
09:54 ET | 1701 | 0.756008 |
09:56 ET | 1625 | 0.7621 |
09:57 ET | 3153 | 0.7581 |
09:59 ET | 477 | 0.760997 |
10:01 ET | 1841 | 0.7622 |
10:06 ET | 1200 | 0.755 |
10:08 ET | 1362 | 0.7621 |
10:10 ET | 9709 | 0.7652 |
10:14 ET | 890 | 0.7792 |
10:33 ET | 5975 | 0.7784 |
10:35 ET | 2000 | 0.771593 |
10:39 ET | 100 | 0.775 |
10:42 ET | 100 | 0.775 |
10:53 ET | 100 | 0.776 |
10:57 ET | 125 | 0.7751 |
11:02 ET | 270 | 0.7771 |
11:04 ET | 1854 | 0.7771 |
11:06 ET | 137 | 0.775 |
11:09 ET | 328 | 0.7751 |
11:20 ET | 310 | 0.778 |
11:24 ET | 200 | 0.7785 |
11:31 ET | 1260 | 0.7786 |
11:36 ET | 700 | 0.7797 |
11:38 ET | 800 | 0.7898 |
11:49 ET | 195 | 0.7797 |
12:02 ET | 27673 | 0.8 |
12:03 ET | 5265 | 0.81 |
12:05 ET | 1899 | 0.8099 |
12:07 ET | 280 | 0.807212 |
12:14 ET | 1467 | 0.81 |
12:16 ET | 100 | 0.8099 |
12:20 ET | 172 | 0.8099 |
12:21 ET | 2157 | 0.8067 |
12:23 ET | 900 | 0.8067 |
12:27 ET | 100 | 0.8099 |
12:30 ET | 146 | 0.8083 |
12:36 ET | 2000 | 0.8098 |
12:43 ET | 200 | 0.8075 |
12:45 ET | 2795 | 0.815 |
12:48 ET | 228 | 0.8095 |
12:59 ET | 100 | 0.807 |
01:03 ET | 826 | 0.80925 |
01:15 ET | 1036 | 0.807045 |
01:17 ET | 100 | 0.807 |
01:21 ET | 347 | 0.8115 |
01:24 ET | 352 | 0.8105 |
01:33 ET | 100 | 0.8115 |
01:48 ET | 100 | 0.8115 |
01:53 ET | 620 | 0.815 |
01:55 ET | 100 | 0.8171 |
01:57 ET | 100 | 0.8115 |
02:02 ET | 5409 | 0.8115 |
02:04 ET | 100 | 0.8006 |
02:06 ET | 300 | 0.8006 |
02:08 ET | 100 | 0.8006 |
02:09 ET | 100 | 0.8007 |
02:11 ET | 599 | 0.8143 |
02:13 ET | 100 | 0.8022 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cara Therapeutics Inc | 43.2M | -0.4x | --- |
ImmuCell Corp | 39.8M | -6.9x | --- |
Aadi Bioscience Inc | 49.1M | -0.8x | --- |
Prenetics Global Ltd | 70.5M | -1.2x | --- |
Turnstone Biologics Corp | 69.8M | -1.2x | --- |
Celularity Inc | 67.1M | -0.3x | --- |
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back. It is conducting Phase II/III Clinical Program in NP. The program is comprised of two studies - KOURAGE 1 and KOURAGE 2, which are double-blind, placebo-controlled, eight-week studies with patients allowed to roll-over into open-label 52-week extensions. It has developed an IV formulation of difelikefalin, for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $43.2M |
---|---|
Revenue (TTM) | $21.0M |
Shares Outstanding | 54.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.82 |
EPS | $-2.19 |
Book Value | $1.05 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -579.43% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.